TKI258 for Metastatic Inflammatory Breast Cancer Patients
Condition:   Breast CancerIntervention:   Drug: DovitinibSponsors:   M.D. Anderson Cancer Center;   NovartisRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2010 Category: Research Source Type: clinical trials

MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
Condition:   Breast CancerIntervention:   Sponsor:   City of Hope Medical CenterRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 29, 2010 Category: Research Source Type: clinical trials

MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
Condition:   Breast CancerIntervention:   Sponsor:   City of Hope Medical CenterRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2010 Category: Research Source Type: clinical trials

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer
Condition:   Breast CancerInterventions:   Drug: Panitumumab;   Drug: Nab-paclitaxel;   Drug: Carboplatin;   Drug: 5-Fluorouracil;   Drug: Epirubicin;   Drug: CyclophosphamideSponsors:   M.D. Anderson Cancer Center;   Celgene Corporation;   AmgenRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2009 Category: Research Source Type: clinical trials

Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients
Condition:   Breast CancerInterventions:   Biological: bevacizumab;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: epirubicin hydrochloride;   Drug: fluorouracilSponsor:   UNICANCERActive, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2009 Category: Research Source Type: clinical trials

Case-Control Study of Inflammatory Breast Cancer in North Africa
Condition:   Inflammatory Breast CancerIntervention:   Sponsor:   National Cancer Institute (NCI)Recruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2008 Category: Research Source Type: clinical trials

Case-Control Study of Inflammatory Breast Cancer in North Africa
Condition:   Inflammatory Breast CancerIntervention:   Sponsor:   National Cancer Institute (NCI)Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2008 Category: Research Source Type: clinical trials

Case-Control Study of Inflammatory Breast Cancer in North Africa
Condition:   Inflammatory Breast CancerIntervention:   Sponsor:   National Cancer Institute (NCI)Recruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2008 Category: Research Source Type: clinical trials

Inflammatory Breast Cancer (IBC) Registry
Condition:   Breast CancerInterventions:   Other: Interview;   Procedure: Blood and Tissue CollectionSponsors:   M.D. Anderson Cancer Center;   Susan G. Komen Breast Cancer FoundationRecruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2007 Category: Research Source Type: clinical trials